Every financial statement,
one clean chart.
Search any US-listed company. Data straight from SEC filings.
Lantheus Holdings, Inc. (LNTH), most recent 12 months reported: revenue $1.56B, net income $275.31M, free cash flow $387.83M. Latest balance sheet on file: liquid cash $593.3M, total debt $571.05M, net cash $22.25M. From SEC filings. More on Lantheus Holdings, Inc.: Revenue · Profitability · Cash flow · Debt Others in In Vitro & In Vivo Diagnostic Substances: IDEXX LABORATORIES INC /DE · QUIDELORTHO CORP · Neogen Corporation · MYRIAD GENETICS, INC. · INTELLIA THERAPEUTICS, INC. · Alpha Teknova, Inc. · ImmuCell Corporation · Anbio Biotechnology
Filter every US company by the numbers — net cash, margins, ROIC, growth. Looking for one company? The search box above is free.
Follow a company and we'll email you when it files a quarterly or annual report with the SEC. Free follows 3 companies; Pro follows up to 500, and sorts and filters them.